Since July 2019, PX’Therapeutics became a brand of Promise Proteomics. Promise Proteomics is the company resulting from the merge, in 2019, of two companies owned by Aguettant group and constituting until this merge the Biotech hub, PX’Therapeutics and Promise Advanced Proteomics. Both companies were acquired by Aguettant group in 2012. The two societies’ names are now used as brand names and the new company is renamed as PROMISE PROTEOMICS. Created in 2000 in Grenoble, PX’Therapeutics is a company renowned for its expertise in recombinant protein bioproduction. Today following the merge, expertise has evolved and the company offers the bioproduction of customized Stable isotope Labelled proteins. Please Visite promise proteomics wensite for more information : https://promise-proteomics.com/services/custom-production-of-sil-proteins